Protective effect of docosahexaenoic acid against cyclosporine a-induced nephrotoxicity in rats: A possible mechanism of action

Renal Failure

Volumn 33, Issue 1, 2011, Pages 66-71

  Mariee, Amr Darwish ^a,b   Abd Ellah, Mohamed Fahmy ^a  

^a Al Azhar University   (Egypt)

^b TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

CsA; DHA; Nephrotoxicity; NO; Rat

Indexed keywords

CHOLESTEROL; CYCLOSPORIN A; DOCOSAHEXAENOIC ACID; N ACETYL BETA GLUCOSAMINIDASE; NITRIC OXIDE; TRIACYLGLYCEROL; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG MECHANISM; ENZYME INHIBITION; HYPERLIPIDEMIA; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RAT; RENAL PROTECTION; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

ANIMALS; CYCLOSPORINE; DOCOSAHEXAENOIC ACIDS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78651343811     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.541584     Document Type: Article

References (54)

1. Calne R, White D, Thiru S, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet. 1978;2(8104-8105):1323-1327.
2. Busauschina A, Schnuelle P, Vander Woude F. Cyclosporine nephrotoxicity. Transplant Proc. 2004;36(2):229S-233S.
3. Li C, Lim S, Sun B, Yang C. Chronic cyclosporine nephrotox-icity: New insights and preventive strategies. Yonsei Med J. 2004;45(6):1004-1016.
4. English J, Evan A, Houghton D, Bennett W. Cyclosporin-induced acute renal dysfunction in the rat. Evidence of arteri-olar vasoconstriction with preservation of tubular function. Transplantation. 1987;44(1):135-141.
5. Gossmann J, Radounikli A, Bernemann A, et al. Pathophysiol-ogy of cyclosporine-induced nephrotoxicity in humans: A role for nitric oxide? Kidney Blood Press Res. 2001;24(2):111-115.
6. Kon V, Sugiura M, Inagami T, Harvie B, Ichikawa I, Hoover R. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int. 1990;37:1487-1491.
7. Shihab F, Hong Y, Bennett W, Andoh T. Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity. Kidney Int. 2000;58(3):1174-1185.
8. Vaziri N, Ni Z, Zhang Y, Ruzics E, Maleki P, Ding Y. Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension. Kidney Int. 1998;54: 482-491. (Pubitemid 28357411)
9. Burdmann E, Andoh T, Yu L, Bennett W. Cyclosporine nephrotoxicity. Semin Nephrol. 2003;23(5):465-476.
10. Parra Cid T, Conejo Garcia J, Carballo Alvarez F, de Arriba G. Antioxidant nutrients protect against cyclosporine A neph-rotoxicity. Toxicology. 2003;189(1-2):99-111.
11. Wongmekiat O, Leelarugrayub N, Thamprasert K. Beneficial effect of shallot (Allium ascalonicum L.) extract on cyclospo-rine nephrotoxicity in rats. Food Chem Toxicol. 2008;46(5): 1844-1850.
12. Ghaznavi R, Zahmatkesh M, Kadkhodaee M, Mahdavi-Maz-deh M. Cyclosporine effects on the antioxidant capacity of rat renal tissues. Transplant Proc. 2007;39(4):866-867.
13. Gökçe A, Oktar S, Yönden Z, et al. Protective effect of caffeic acid phenethyl ester on cyclosporine A-induced nephrotoxicity in rats. Ren Fail. 2009;31(9):843-847.
14. Pari L, Sivasankari R. Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats. Fundam Clin Pharmacol. 2008;22(4):395-401.
15. Wongmekiat O, Thamprasert K. Investigating the protective effects of aged garlic extract on cyclosporine-induced nephro-toxicity in rats. Fundam Clin Pharmacol. 2005;19(5):555-562.
16. Hirunpanich V, Murakoso K, Sato H. Inhibitory effect of docosahexaenoic acid (DHA) on the intestinal metabolism of midazolam: In vitro and in vivo studies in rats. Int J Pharm. 2008;351(1-2):133-143.
17. Harris W, Rambjor G, Windsor S, Diederich D. n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr. 1997;65:459-464.
18. Nenseter M, Drevon C. Dietary polyunsaturates and peroxidation of low density lipoprotein. Curr Opin Lipidol. 1996; 7(1):8-13.
19. Pan H, Kao T, Ou Y, et al. Protective effect of docosa-hexaenoic acid against brain injury in ischemic rats. J Nutr Biochem. 2009;20(9):715-725.
20. Robinson J, Stone N. Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. Am J Cardiol. 2006;98(4A):39i-49i.
21. Song J, Fujimoto K, Miyazawal T. Polyunsaturated (n-3) Fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid-containing oils. J Nutr. 2000;130(12):3028-3033.
22. Fossati P, Prencipe L. Serum triglycerides determined colori-metrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28(10):2077- 2080.
23. Roeschlau P, Bernt E, Gruber W. Enzymatic determination of total cholesterol in serum. Z Klin Chem Klin Biochem. 1974; 12(5):226-230.
24. Hallet G, Cook J. Reduced nicotinamide adenine dinucleotide for emergency blood urea estimation. Clin Chim Acta. 1971;35(1):33-37.
25. Bonsnes R, Taussky H. On the colorimetric determination of creatinine by the Jaff reaction. J Biol Chem. 1945;158:581-591.
26. Moore J, Morris J. A simple automated colorimetric method for determination of N-acetyl-b-D-glucosaminidase. Ann Clin Biochem. 1982;19(3):157-159.
27. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271-278.
28. Levine R, Garland D, Oliver C, et al. Determination of carbo-nyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464-478.
29. Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, Tan-nenbaum S. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem. 1982;126(1):131-138.
30. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1): 265-275.
31. Atessahin A, Ceribasi A, Yilmaz S. Lycopene a carotenoid, attenuates cyclosporine-induced renal dysfunction and oxida-tive stress in rats. Basic Clin Pharmacol Toxicol. 2007;100(6): 372-376.
32. Mohamadin A, El-Beshbishy H, El-Mahdy M. Green tea extract attenuates cyclosporine A-induced oxidative stress in rats. Pharmacol Res. 2005;51(1):51-57.
33. Shi S, Zheng S, Jia C, Zhu Y, Xie H. Inhibitory effect of tea polyphenals on transforming growth factor-beta1 expression in rat with cyclosporine A-induced chronic nephrotoxicity. Acta Pharmacol Sin. 2004;25(1):98-103.
34. Cheng C, Hsieh C, Shu K, Chen Y, Chen H. Effect of calcium channel antagonist diltiazem and calcium ionophore A23187 on cyclosporine A induced apoptosis of renal tubular cells. FEBS Lett. 2002;516(1-3):191-196.
35. Satyanarayana P, Chopra K. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: Attenuation by tri-metazidine. Ren Fail. 2002;24(3):259-274.
36. Tirkey N, Kaur G, Vij G, Chopra K. Curcumin a diferuloyl-methane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacol. 2005;5: 15-24.
37. Chander V, Chopra K. Effect of molsidomine and l-arginine in cyclosporine nephrotoxicity: Role of nitric oxide. Toxicology. 2005;207(3):463-474.
38. De Nicola L, Thomson S, Wead L, Brown M, Gabbai F. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest. 1993;92(4):1859-1865.
39. Sabry A, El-Husseini A, Sheashaa H, et al. Colchicine vs. omega-3 fatty acids for prevention of chronic cyclosporine nephrotoxicity in Sprague Dawley rats: An experimental animal model. Arch Med Res. 2006;37(8):933-940.
40. Diederich D, Skopec J, Diederich A, Dai F. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension. 1994;23(6 Pt 2):957-961.
41. Kim Y, Chung H. Antioxidative and anti-inflammatory actions of docosahexaenoic acid and eicosapentaenoic acid in renal epithelial cells and macrophages. J Med Food. 2007; 10(2):225-231.
42. El-Mesery M, Al-Gayyar M, Salem H, Darweish M, E-Mowafy A. Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): Implications of CRP and lipid peroxides. Cell Div. 2009;(4):6-22.
43. Kubo K, Saito M, Tadokoro T, Maekawa A. Preferential incorporation of docosahexaenoic acid into nonphosphorus lipids and phosphatidylethanolamine protects rats from dietary DHA-stimulated lipid peroxidation. J Nutr. 2000;130(7): 1749-1759.
44. Bouzidi N, Mekki K, Boukaddoum A, Dida N, Kaddous A, Bouchenak M. Effects of omega-3 polyunsaturated fatty acid supplementation on redox status in chronic renal failure patients with dyslipidemia. J Ren Nutr. 2010;20(5):321-328.
45. Calviello G, Palozza P, Franceschelli P, Bartoli G. Low-dose eicosapentaenoic or docosahexaenoic acid administration modifies fatty acid composition and does not affect susceptibility to oxidative stress in rat erythrocytes and tissues. Lipids. 1997;32(10):1075-1083.
46. Sunada S, Kiyose C, Kubo K, Takebayashi J, Sanada H, Saito M. Effect of docosahexaenoic acid intake on lipid peroxidation in diabetic rat retina under oxidative stress. Free Radic Res. 2006;40(8):837-846.
47. Taccone-Gallucci M, Manca-di-Villahermosa S, Battistini L, Stuffler R, Tedesco M, Maccarrone M. N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int. 2006;69(8): 1450-1454.
48. Cattel V. Nitric oxide-potential mediator in glomerulonephri-tis. Nephrol Dial Transplant. 1995;10:759-774.
49. Mumtaz F, Dashwood M, Khan M, Thompson C, Mikhailidis D, Morgan R. Down-regulation of nitric oxide synthase in the diabetic rabbit kidney: Potential relevance to the early patho-genesis of diabetic nephropathy. Curr Med Res Opin. 2004; 20(1):1-6.
50. Prabhakar S. Pathogenic role of nitric oxide alterations in diabetic nephropathy. Curr Diab Rep. 2005;5:449-454.
51. Raij L, Baylis C. Glomerular action of nitric oxide. Kidney Int. 1995;48(1):20-32.
52. Pacher P, Obrosova I, Mabley J, Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications: Emerging new therapeutical strategies. Curr Med Chem. 2005;12:267-275.
53. Prabhakar S, Starnes J, Shi S, Lonis B, Tran R. Diabetic nephr-opathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol. 2007;18:2945-2952.
54. Shimokawa H, Vanhoutte P. Dietary cod-liver oil improves endothelium dependent responses in hypercholesterolemic and atherosclenotic porcine coronary arteries. Circulation. 1988;78(6):1421-1430.